Azenta, Inc. (AZTA)

Market Cap	1.72B
Revenue (ttm)	593.82M
Net Income (ttm)	-55.76M
Shares Out	45.99M
EPS (ttm)	-1.22
PE Ratio	n/a
Forward PE	47.57
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,243,485
Open	36.45
Previous Close	36.50
Day's Range	36.44 - 38.17
52-Week Range	23.91 - 55.64
Beta	1.29
Analysts	Strong Buy
Price Target	43.60 (+16.27%)
Earnings Date	Nov 21, 2025

About AZTA

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sampl...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Feb 1, 1995
• Employees: 3,000
• Stock Exchange: NASDAQ
• Ticker Symbol: AZTA
• Website: https://www.azenta.com

Financial Performance

In 2025, Azenta's revenue was $593.82 million, an increase of 3.55% compared to the previous year's $573.45 million. Losses were -$55.76 million, -66.18% less than in 2024.

Analyst Summary

According to 5 analysts, the average rating for AZTA stock is "Strong Buy." The 12-month stock price target is $43.6, which is an increase of 16.27% from the latest price.

Price Target

$43.6

(16.27% upside)

Analyst Consensus: Strong Buy